Local Institution - 0008 — Nashville, Tennessee

Local Institution - 0008 is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Local Institution - 0008 has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Relapsed and/or Refractory Multiple Myeloma, Stage IV or Recurrent Non-Small Cell Lung Cancer, Brain Neoplasms.

Sponsors: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company, Bristol-Myers Squibb.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 0008?

Local Institution - 0008 has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 0008 conducted?

Local Institution - 0008 has 3 clinical trials on record, with 1 currently active. Their work covers Relapsed and/or Refractory Multiple Myeloma, Stage IV or Recurrent Non-Small Cell Lung Cancer, Brain Neoplasms.

Is Local Institution - 0008 accredited by Crixeo Health?

Local Institution - 0008 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 0008?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.